Startups
Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible.
Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.
Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.
Overview
Location
Israel, Haifa District, Haifa
Employees
11-50
Founded date
2012
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 23, 2021 | Four exciting companies receive expert mentoring | Four promising healthcare start-ups have proven the viability of their innovations and business plans in a competitive EIT Health Gold Track workshop in February. These start-ups have been selected to progress to the next stage of the prog... |
Reviews 0
FAQ about Minovia Therapeutics
When was Minovia Therapeutics founded?
Minovia Therapeutics was founded in 2012.
What has the press written about Minovia Therapeutics?
Parsers VC has collected 2 articles mentioning Minovia Therapeutics, among them “Four exciting companies receive expert mentoring” (Feb 23, 2021).
Is Minovia Therapeutics still active?
Yes, Minovia Therapeutics is active; its latest activity on Parsers VC dates from Feb 20, 2025.